The rollout of the antiviral medicine used to reduce the risk of HIV, Lenacapavir, has brought hope to the South African government.
Deputy President, Paul Mashatile who is also the Chairperson of the South African National AIDS Council (SANAC), expressed optimism during the first Extended Plenary engagement of the year.
The official rollout of Lenacapavir is expected to occur in six provinces between April and June this year, as announced by Health Minister, Dr Aaron Motsoaledi, following its registration with the South African Health Products Regulatory Authority (SAHPRA) in October 2025.
The Deputy President acknowledged progress made in the fight against HIV/AIDS thus far but believes the introduction of Lenacapavir will significantly decrease infections.
“Together we can accelerate progress towards the 95-95-95 targets. The targets call for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression”, Mashatile outlined.
As the country commemorates World TB Day on the 24th of March, Mashatile called for more concerted efforts towards ending TB.
“As we observe this day under the theme “Yes! You and I Can End TB”, let us recommit ourselves to turning words into action. Ending TB and HIV is a moral duty to restore dignity, protect families and secure the future of our nation. I call on all of us to strengthen collaboration, to break down barriers of stigma and inequality, and to mobilise every resource at our disposal”, said Mashatile.
He concluded by urging all relevant partners to unite in the fight against Gender-Based Violence and Femicide (GBVF), especially as it was declared a national disaster.
